Chih-Hsin Yang
National Taiwan University Hospital · National Taiwan University College of Medicine · Deparment of Oncology, National Taiwan University Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Chih-Hsin Yang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 22:23 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT03819465 · A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLCAstraZeneca · active not recruiting · Metastatic Non-Small Cell Lung Cancer (NSCLC) · principal investigator
- Ph1/Ph2NCT02025114 · Selumetinib in Combination With Gefitinib in NSCLC PatientsNational Taiwan University Hospital · completed · Non-small Cell Lung Cancer (NSCLC) · principal investigator
- N/ANCT02002117 · Genotyping of Non-small Cell Lung CancerNational Taiwan University Hospital · unknown · Non-small Cell Lung Cancer, Gene Abnormality · principal investigator
- Ph2NCT01922583 · AUY922 in Patient With Stage IV NSCLCNational Taiwan University Hospital · completed · Non-small Cell Lung Cancer (NSCLC) · principal investigator
- N/ANCT01637597 · Crizotinib Efficacy In Non-Small Cell Lung Cancer Patients With Anaplastic Lymphoma Kinase TranslocationNational Taiwan University Hospital · unknown · Non-small Cell Lung Cancer(NSCLC) · principal investigator
- Ph1NCT01147211 · Dose Defining Study For MK-2206 Combined With Gefitinib In Non Small Cell Lung Cancer (NSCLC)National Taiwan University Hospital · unknown · Non Small Cell Lung Cancer · principal investigator
- N/ANCT00977509 · Gene Mutations in Non-Small Cell Lung Cancer CellsNational Taiwan University Hospital · unknown · Carcinoma, Non-Small-Cell Lung · principal investigator
- Ph3NCT00360841 · Stimulation of Auricular Acupuncture-Point for Chemotherapy-Induced Nausea/VomitingNational Taiwan University Hospital · completed · Cancer · principal investigator
- Ph2NCT00173888 · Docetaxel Plus Cisplatin Followed by Gemcitabine Versus Gemcitabine Plus Cisplatin Followed by Docetaxel for Non-Small Cell Lung Cancer (NSCLC)National Taiwan University Hospital · completed · Non-small Cell Lung Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 22:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 22:23 UTC. The ranking covers the 200 most relevant of 1216 PubMed records, and a shared surname and initials can bring in a namesake. All 1216 on PubMed
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.Lancet · 20202,489 citationsRCR 131.1
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis.N Engl J Med · 20182,438 citationsRCR 92.5
- Precision Microbiome Modulation with Discrete Dietary Fiber Structures Directs Short-Chain Fatty Acid Production.Cell Host Microbe · 2020416 citationsRCR 21.6
- Durvalumab With or Without Tremelimumab in Combination With Chemotherapy as First-Line Therapy for Metastatic Non-Small-Cell Lung Cancer: The Phase III POSEIDON Study.J Clin Oncol · 2023410 citationsRCR 31.4
- 221 citationsRCR 22.1
- Randomized, controlled trial of TNF-α antagonist in CTL-mediated severe cutaneous adverse reactions.J Clin Invest · 2018219 citationsRCR 11.5
- Safety and efficacy of tocilizumab versus azathioprine in highly relapsing neuromyelitis optica spectrum disorder (TANGO): an open-label, multicentre, randomised, phase 2 trial.Lancet Neurol · 2020216 citationsRCR 10.9
- 169 citationsRCR 16.1
- Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancer.Ann Oncol · 2021166 citationsRCR 7.3
- Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Randomized Controlled Trial.Am J Kidney Dis · 2019157 citationsRCR 7.8